Implication of TEL-derived proteins in oncogenesis;Implication des proteines derivees de TEL dans l'oncogenese

Hematologie

Volumn 5, Issue 2, 1999, Pages 143-151

  Carron, Clémence ^a   Lopez, Rodolphe ^a   Cormier, Françoise ^a   Boureux, Anthony ^a   Tran Quang, Christine ^a   Bernard, Olivier ^b   Ghysdael, Jacques ^a  

^a CNRS   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

AML1; Chromosomal translocations; Leukemia; TEL; Tyrosine kinases

Indexed keywords

CHIMERIC PROTEIN; DNA BINDING PROTEIN; NEUROTROPHIN RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOMONOCYTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; GENE REARRANGEMENT; HUMAN; LEUKEMIA; LEUKEMOGENESIS; PROTEIN DOMAIN; REVIEW; TRANSCRIPTION REGULATION;

EID: 0033059056     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Ghysdael J, Boureux A The ETS family of transcriptional regulators. In: Oncogenes as transcriptional regulators, vol 1. Basel-Boston-Berlin, Birkhauser Verlag, 1997 29-88
2. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994, 77 307-16.
3. Baens M, Peeters P, Guo C, Aerssens J, Marynen P. Genomic organization of TEL: the human ETS-vanant gene 6 Genome Research 1996, 6: 404-13.
4. Poirel H, Oury C, Carron C, Duprez E, Laabi Y, Tsapis A, Romana SP, Mauchauffe M, Le Coniat M, Berger R, Ghysdael J, Bernard OA. The TEL gene products: nuclear phosphoproteins with DNA binding properties Oncogene 1997, 14 349-57.
5. Bornemann D, Miller E, Simon J The drosophila polycomb group gene sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein Development 1996; 122 1621-30
6. Slupsky CM, Gentile LN, Donaldson LW, Mackereth CD, Seidel JJ, Graves B, McIntosh LP. Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site. Proc Natl Acad Sci USA 1998, 95, 12129-34
7. Jousset C, Carron C, Boureux A, Tran Quang C, Oury C, Dusanter-Fourt I, Charon M, Levin J, Bernard O, Ghysdael J A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein EMBO J 1997, 16 69-82
8. Sotijn DP, Gunster MJ, von der Vlag J, Hamer KM, Schul W, Alkema MJ, Saurin AJ, Freemont PS, van Driel R, Otte AP RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor Mol Cell Biol 1997, 17: 4105-13.
9. Peterson AJ, Kyba M, Bornemann D, Morgan K, Brock HW, Simon J A domain shared by the polycomb group proteins Scm and ph mediates heterotypic and homotypic interactions Mol Cell Biol 1997, 17: 6683-92.
10. Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL EMBO J 1997; 16 4374-83.
11. Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F, Alt FW, Gilliland DG, Golub TR, Orkin SH The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow Genes & Development 1998, 12 2392-402
12. Heldin CH, Ernlund A, Rorsman C, Ronnstrand L Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation J Biol Chem 1989, 264 8905-12
13. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proc Nat Acad Sci USA 1996, 93. 14845-50
14. Bourgeade MF, Defachelles AS, Cayre YE Myc is essential for transformation by TEL/platelet-derived growth factor receptor beta (PDG-FRbeta). Blood 1998; 91 3333-9
15. Besancon F, Atfi A, Gespach C, Cayre YE, Bourgeade MF Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TH/platelet-derived growth factor receptor beta fusion protein. Proc Nat Acad Sci USA 1998, 95: 8081-6.
16. McWhirter JR, Wang JY. Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins Mol Cell Biol 1991, 11. 1553-65
17. McWhirter JR, Galasso DL, Wang JY. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol 1993, 13 7587-95.
18. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM The novel activation of ABL by fusion to an ets-related gene, TEL Cancer Res 1995, 55. 34-8
19. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia Mol Cell Biol 1996, 16: 4107-16
20. Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F, Hoglund M BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion Genes, Chrom Canc 1997, 20 299-304
21. Okuda K, Golub TR, Gilliland DG, Griffin JD p21OBCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines Oncogene 1996, 13 1147-52
22. Janssen JW, Ridge SA, Papadopoulos P, Cotter F, Ludwig WD, Fonatsch C, Rieder H, Ostertag W, Barrram CR, Wiedemann LM The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event Br J Haematol 1995; 90: 222-4
23. Lacronique V, Boureux A, Valle VD, Poirel H, Tran Quang C, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OAA TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 1997, 278 1309-12
24. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P, Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9,15;12) in a myeloid leukemia Blood 1997, 90 2535-40.
25. Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaria Jr R, Marynen P, Gilliland DG Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes EMBO J 1998, 17 5321-33
26. Luo H, Rose P, Barber D, Hanratty WP, Lee S, Robens TM, D'Andrea AD, Dearolf CR. Mutation in the Jak kinase JH? domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol 1997, 17: 1562-71
27. Knezevich SR, McFadden DE, Tao W, Lim, JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nature Genetics 1998, 18 184-7
28. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffe M, Jonveaux P, Macintyre EA, Berger R, Bernard OA High frequency of t(12,21) in childhood B-lineage acute lymphoblastic leukemia Blood 1995, 86 4263-9
29. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA The t(12,21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995; 85 3662-70.
30. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995, 9295 4917-21
31. Poirel H, Lacronique V, Mauchauffe M, Le Coniat M, Raffoux E, Daniel MT, Erickson P, Drabkin H, MacLeod RA, Drexler HG, Ghysdael J, Berger R, Bernard OA Analysis of TEL proteins in human leukemias. Oncogens 1998; 16 2895-903.
32. Speck NA, Terryl S A new transcription factor family associated with human leukemias Crit Rev Eukaryot Gene Expr 1995, 5: 337-64
33. Aronson, BD, Fisher AL, Blechman K, Caudy M, Gergen JP. Groucho-dependent and -in dependent repression activities of Runt domain proteins Mol Cell Biol 1997; 17: 5581-7
34. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84 321-30
35. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis Proc Nat Acad Sci USA 1996; 93 3444-9.
36. Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K, Tani Y, Kishimoto T, Komori T. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta Proc Nat AcadSci USA 1996; 93 12359-63
37. Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bones JC, Alt FW, Ryan G, Liu PP, Wynshaw-Boris A, Binder M, Marin-Padilla M, Sharpe AH, Speck NA The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell 1996, 87. 697-708
38. Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussell MF, Gilliland DG, Lenny N, Meyers S The t(12,21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 1996; 16: 1349-55
39. Romana SP, Le Coniat M, Poirel H, Marynen P, Bernard O, Berger R Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). 1996; 10 167-70
40. Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B The 12,21 translocation involving TEL and deletion of the other TEL allele two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996, 87: 2891-9
41. Cave H, Cacheux V, Raynaud S, Brunie G, Bakkus M, Cochaux P, Preudhomme C, Lai JL, Vilmer E, Grandchamp B ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia Leukemia 1997, 11. 1459-64.
42. Kim DH, Moldwin RL, Vignon C, Bohlander SK, Suto Y, Giordano L, Gupta R, Fears S, Nucifora G, Rowley JD TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines Blood 1996, 88 785-94
43. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JW, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR. TEL/AML-1 dimenzes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia Blood 1996; 88 4252-8.
44. Rubnitz JE, Downing JR, Pui CH, Shurtleff S A, Raimondi SC, Evans WE, Head DR, Crist WM, Rivera GK, Hancock ML, Boyeti JM, Buijs A, Grosveld G, Behm FG TEL gene rearrangement in acute lymphoblastic leukemia a new genetic marker with prognostic significance J Clin Oncol 1997, 15. 1150-7
45. Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta BM, Pui CH, Downing JR, Behm FG Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy a pediatric oncology group study Blood 1997, 89 1143-6.
46. Borkhardi A, Cazzaniga G, Viehmann S, Volsecchi MG, Ludwig WD, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster Siudy Group Blood 1997, 90 571-7
47. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse Blood 1997; 90 4933-7
48. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A, Grosveld G Translocation (12:22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11 Oncogene 1995; 10: 1511-9